Evidence map›Paper›PMID 20724476›Full record

ArticleThe Journal of biological chemistry2010

p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.

Manoj B Menon, Jessica Schwermann, Anurag Kumar Singh, Mirita Franz-Wachtel, Oliver Pabst, Ursula Seidler, M Bishr Omary, Alexey Kotlyarov, Matthias Gaestel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. CK8/18 and Claudin Profile of Female Breast Cancers from Botswana.Breast cancer : basic and clinical research · 2026
    Article
  2. Article
  3. SRC and ERK Regulate the Turnover of Cytoskeletal Keratin Filaments.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Frontiers in cell and developmental biology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges.Frontiers in cell and developmental biology · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Manoj B MenonFrom the Institute of Biochemistry, Hannover 30625, Germany.
Jessica SchwermannFrom the Institute of Biochemistry, Hannover 30625, Germany.
Anurag Kumar SinghDepartment of Gastroenterology, Hepatology, and Endocrinology, Hannover 30625, Germany.
Mirita Franz-WachtelProteome Center Tübingen, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen 72076, Germany.
Oliver PabstInstitute of Immunology, Medical School Hannover, Hannover 30625, Germany.
Ursula SeidlerDepartment of Gastroenterology, Hepatology, and Endocrinology, Hannover 30625, Germany.
M Bishr OmaryDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan 48109.
Alexey KotlyarovFrom the Institute of Biochemistry, Hannover 30625, Germany.
Matthias GaestelFrom the Institute of Biochemistry, Hannover 30625, Germany. Electronic address: gaestel.matthias@mh-hannover.de.
Medizinische Hochschule Hannover · DEUniversity of Michigan–Ann Arbor · USUniversity of Tübingen · DE

Funding

Keratin Biology and Disease Aspects in Simple EpitheliaR01DK047918 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1995 to 2018
$6.6M
NIDDK NIH HHS DK47918NIDDK NIH HHS R01 DK047918
6 · The paper itself

Abstract

The MAPK-activated protein kinases (MAPKAP kinases) MK2 and MK3 are directly activated via p38 MAPK phosphorylation, stabilize p38 by complex formation, and contribute to the stress response. The list of substrates of MK2/3 is increasing steadily. We applied a phosphoproteomics approach to compare protein phosphorylation in MK2/3-deficient cells rescued or not by ectopic expression of MK2. In addition to differences in phosphorylation of the known substrates of MK2, HSPB1 and Bag-2, we identified strong differences in phosphorylation of keratin 8 (K8). The phosphorylation of K8-Ser(73) is catalyzed directly by p38, which in turn shows MK2-dependent expression. Notably, analysis of small molecule p38 inhibitors on K8-Ser(73) phosphorylation also demonstrated reduced phosphorylations of keratins K18-Ser(52) and K20-Ser(13) but not of K8-Ser(431) or K18-Ser(33). Interestingly, K18-Ser(52) and K20-Ser(13) are not directly phosphorylated by p38 in vitro, but by MK2. Furthermore, anisomycin-stimulated phosphorylations of K20-Ser(13) and K18-Ser(52) are inhibited by small molecule inhibitors of both p38 and MK2. MK2 knockdown in HT29 cells leads to reduced K20-Ser(13) phosphorylation, which further supports the notion that MK2 is responsible for K20 phosphorylation in vivo. Physiologic relevance of these findings was confirmed by differences of K20-Ser(13) phosphorylation between the ileum of wild-type and MK2/3-deficient mice and by demonstrating p38- and MK2-dependent mucin secretion of HT29 cells. Therefore, MK2 and p38 MAPK function in concert to phosphorylate K8, K18, and K20 in intestinal epithelia.

Indexed as

AnimalsCell LineIleumIntestinal MucosaIntracellular Signaling Peptides and ProteinsKeratinsMAP-Kinase-Activated Kinase 2MiceMice, Knockoutp38 Mitogen-Activated Protein KinasesPhosphorylationProtein Kinase InhibitorsProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsKeratinsMAP-Kinase-Activated Kinase 2MAP-kinase-activated kinase 3p38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsProtein Serine-Threonine Kinases

Identifiers

PMID20724476
PMCPMC2963412
OpenAlexW1972294572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.